AmerisourceBergen Announces Date and Time for Earnings Release, Conference Call and Webcast
Participating in the conference call will be:R. David Yost, President & Chief Executive Officer Kurt J. Hilzinger, Executive Vice President & Chief Operating Officer Michael D. DiCandilo, Senior Vice President & Chief Financial Officer
The dial-in numbers for the live call will be as follows:877-777-1972 from within the United States. No access code required. 612-332-7515 from outside the United States. No access code required.
In order to ensure the widest distribution possible, the Company will be broadcasting the conference call over the Internet. The call will be accessible through AmerisourceBergen's web site, www.amerisourcebergen.com, and also through Street Events, www.streetevents.com. Users are encouraged to log on to the webcast approximately 15 minutes in advance of the scheduled start time of the call.
Following the live call, replays will be made available on the Internet and via telephone. A replay of the webcast will be posted on www.amerisourcebergen.com approximately two hours after the completion of the call and will remain available for thirty days. To access the telephone replay from within the US, dial 800-475-6701. From outside the US, dial 320-365-3844. The access code is 654935. The telephone replay will be available from 4:15 p.m. EST on 11/5/02 to 11:59 p.m. on 11/12/02.
About AmerisourceBergen CorporationAmerisourceBergen (NYSE:ABC) is the largest pharmaceutical services company in the United States dedicated solely to the pharmaceutical supply chain. It is the leading distributor of pharmaceutical products and services to the hospital systems/acute care market, alternative care providers, independent community pharmacies, and regional chains. The company is also a leader in the institutional pharmacy marketplace. With approximately $40 billion in annualized operating revenues, AmerisourceBergen is headquartered in Valley Forge, PA, and employs more than 13,000 people serving over 25,000 customers.
Forward-Looking StatementsThis press release may contain certain "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These statements are based on management's current expectations and are subject to uncertainty and changes in circumstances. Actual results may vary materially from the expectations contained in the forward-looking statements. The forward-looking statements herein include statements addressing future financial and operating results of AmerisourceBergen and the benefits and other aspects of the merger between AmeriSource Health Corporation and Bergen Brunswig Corporation.
The following factors, among others, could cause actual results to differ materially from those described in the forward-looking statements: the risk that the businesses of AmeriSource and Bergen Brunswig will not be integrated successfully; failure to obtain and retain expected synergies; and other economic, business, competitive and/or regulatory factors affecting the business of AmerisourceBergen generally.
More detailed information about these factors is set forth in AmerisourceBergen's filings with the Securities and Exchange Commission, including its June 30, 2002 Form 10-Q, its Annual Report on Form 10-K for fiscal 2001, and AmeriSource's and Bergen's joint proxy statement-prospectus dated August 1, 2001.
AmerisourceBergen, AmeriSource and Bergen Brunswig are under no obligation to (and expressly disclaim any such obligation to) update or alter their forward-looking statements whether as a result of new information, future events or otherwise.
CONTACT: AmerisourceBergen Corporation, Valley Forge Michael N. Kilpatric, 610/727-7118 email@example.com